LEADS BIOLABS-B to Join Hang Seng Composite Index and Become Eligible for Southbound Trading

Deep News
03/08

LEADS BIOLABS-B (09887) announced that, effective March 9, 2026, the company's shares will be included as a constituent of the Hang Seng Composite Index by Hang Seng Indexes Company Limited and will be added to the list of stocks eligible for the Southbound Stock Connect scheme.

The inclusion in the Hang Seng Composite Index and the Southbound Trading eligibility list represents significant recognition from the capital markets regarding the company's performance and value. This inclusion will permit qualified mainland Chinese investors to directly invest in the company's shares listed on The Stock Exchange of Hong Kong Limited through the Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect mechanisms. The move is anticipated to substantially broaden the company's investor base, enhance the trading liquidity of its shares, and further optimize its shareholder structure.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10